SavedAdd your journal

Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 23 - Sayı: 3

EVALUATION OF MATERNAL HEART DISEASE EFFECTS ON MODE OF DELIVERY AND ADVERSE PERINATAL OUTCOMES: A 10 YEARS’ EXPERIENCE OF A REFERENCE CENTER

Maternal Kalp Hastalığının Doğum Şekli ve Olumsuz Perinatal Sonuçlar Üzerindeki Etkilerinin Değerlendirilmesi: 10 Yıllık Tersiyer Merkez Deneyimi

Mehmet Mete KIRLANGIÇ
YUSUF MADENDAĞ
ERDEM ŞAHİN
Mefkure Eraslan ŞAHİN
İlknur Col MADENDAĞ
Gökhan AÇMAZ
Esra AKDEMİR
Merve VURAL YALMAN
Pages
514–521
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
📊
Key Findings & Data:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
💡
Conclusion & Impact:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Maternal kalp hastalığı · mWHO sınıflandırması · Olumsuz perinatal sonuçlar

Abstract

Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.

Özet

Amaç: Bu çalışmanın amacı, gebelik sırasındaki ciddi maternal kalp hastalığının doğum şekli ve olumsuz perinatal sonuçlar üzerindeki etkisini değerlendirmektir.

🔖

Cite This Article

KIRLANGIÇ, M. M., MADENDAĞ, Y., ŞAHİN, E., ŞAHİN, M. E., MADENDAĞ, İ. C., AÇMAZ, G., AKDEMİR, E., YALMAN, M. V. (2021). EVALUATION OF MATERNAL HEART DISEASE EFFECTS ON MODE OF DELIVERY AND ADVERSE PERINATAL OUTCOMES: A 10 YEARS’ EXPERIENCE OF A REFERENCE CENTER. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 3, 514–521. https://ajindex.com/articles/408895

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hollier LM, Martin Jr JN, Connolly H, Turrentine M, Hameed A, Arendt KW et al. Pregnancy and heart disease. Obstet Gynecol. 2019;133(5):E320-E56
  2. Curry R, Swan L, Steer PJ. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol. 2009;21(6):508-13
  3. Fett JD. Peripartum cardiomyopathy: challenges in diagnosis and management. Expert Rev Cardiovasc Ther. 2016;14(9):1035-41
  4. Hameed AB, Lawton ES, McCain CL, Morton CH, Mitchell C, Main EK et al. Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015;213(3):379.e1-e10
  5. Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118(3):583-91
  6. Kuklina EV, Callaghan WM. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG. 2011;118(3):345-52
  7. Briller J, Koch AR, Geller SE. Maternal cardiovascular mortality in Illinois, 2002–2011. Obstet Gynecol. 2017;129(5):819-26
  8. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118:1-203
  9. Köşüş A, Köşüş N, Açıkgöz N, Çapar M. Kalp hastalığı olan ve olmayan gebelerde maternal ve fetal sonuçlar açisindan bir fark var mı? Genel Tıp Dergisi. 2008;18(2):55-60
  10. Ayşegül Ö, Hamzaoğlu K, Durmaz E, Madazlı R. Pregnancy outcomes of 115 cases with maternal heart disease. İstanbul Tıp Fakültesi Dergisi. 2020;83(1);17-22
  11. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657-65
  12. Pavankumar P, Venugopal P, Kaul U, Iyer K, Das B, Sampathkumar A et al. Pregnancy in patients with prosthetic cardiac valve: a 10-year experience. Scand J Thorac Cardiovasc Surg. 1988;22(1):19-22
  13. Jeejeebhoy FM. Prosthetic heart valves and management during pregnancy. Can Fam Physician. 2009;55(2):155
  14. Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA. Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol. 2015;126(2):346
  15. Erolu E, Sarısoy Ö. Fetal echocardiography characteristics in a tert